GlassScriptPhysician profile
Matthew R Jonovich
NPI 1548378540
$4,506.57
in general payments reported to CMS, 2019-2025
27 companies · $760 in 2025
The $760 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,081 · 2020: $106 · 2021: $420 · 2022: $558 · 2023: $624 · 2024: $957 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,341.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $524.18 | 2019-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $503.58 | 2019-2025 | Ekosonic, Angiojet Ultra 5000a |
| Inari Medical, INC. | $497.28 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $432.41 | 2019 | |
| Shockwave Medical, INC | $405.87 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Novartis Pharmaceuticals Corporation | $371.12 | 2019-2025 | |
| Abbott Laboratories | $311.45 | 2022-2024 | Xact |
| Janssen Pharmaceuticals, INC | $254.92 | 2019-2024 | Xarelto |
| Pfizer INC. | $191.88 | 2019-2024 | |
| Penumbra, INC. | $187.60 | 2023-2025 | Indigo System |
| Cardiva Medical, INC. | $142.50 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire, Ensoetm |
| Teleflex LLC | $108.82 | 2019-2025 | Turnpike, Supercross, Guideliner |
| E.R. Squibb & Sons, L.L.C. | $92.15 | 2019-2025 | Eliquis, Camzyos |
| Terumo Medical Corporation | $81.45 | 2019-2025 | Glidewire, Azur Cx Detachable, Tr Band |
| Medtronic, INC. | $63.74 | 2023-2025 | Corevalve Evolut R |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $47.08 | 2022 | |
| Cardiovascular Systems INC. | $46.94 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $41.51 | 2023 | Uptravi, Opsumit |
| Philips North America LLC | $34.76 | 2020 | |
| Abiomed | $28.42 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.65 | 2025 | Lifevest |
| Bard Peripheral Vascular, INC. | $21.18 | 2021 | |
| Cook Medical LLC | $20.56 | 2019 | |
| Ethicon US, LLC | $20.40 | 2025 | Surgiflo Hemostatic Matrix |
| Verge Medical, INC. | $18.85 | 2019 | |
| Janssen Scientific Affairs, LLC | $18.75 | 2019 | |
| Argon Medical Devices, INC. | $16.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Jonovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.